EUVIMEDEUVIMED entdecken
Crossref

Targeted Analysis of >1500 Plasma Proteoforms via Individual Ion Mass Spectrometry

Aniel Sanchez, Indira Pla iD, Katrina N Peterson, Vincent White iD, Troy D Fisher iD, Michael A R Hollas iD, Taojunfeng Su, Nhat Hoang Van Le, Claire R Harrington, Paolo Cravedi, David N Assis, Paola Barrios und 9 weitere

Journal of Proteome Research · 06.11.2026 · 25 (11) · 5985-6002

DOI: 10.1021/acs.jproteome.6c00449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 08.10.2026. Verfasst von Aniel Sanchez und 20 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics Center of Excellence, Northwestern University, Evanston, Illinois60208, United States. Hauptthemen laut MEDLINE: Proteomics, Mass Spectrometry, Blood Proteins, Proteome. Die Arbeit nennt 71 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasma proteomics has emerged as a powerful approach for interrogating human biology, identifying disease-associated proteomic changes, and advancing precision diagnostics. In recent years, affinity-based plasma proteomics platforms with predefined protein panels, such as Olink and SomaScan, have emerged to complement bottom-up mass spectrometry (BUP). This study leverages a novel mass spectrometry platform to capture targeted proteoform information lost by mainline antibody-, aptamer-, and BUP-driven workflows. The Plasma Proteoform Assay (PPA) uses Individual Ion Mass Spectrometry (I2MS) to resolve mixtures of intact proteins presented by direct injection. Two proteoform panels, PPA 526 and PPA 1514, were defined from human plasma samples obtained from 81 individuals. The panels quantify 526 proteoforms derived from 59 genes and 1,514 proteoforms from 155 genes, respectively. Across both panels, the proportion of targeted proteoforms with CVs below 20% ranged from 59% to 80%. PPA was benchmarked in studies including 9 pooled plasma samples derived from subjects with hepatic cirrhosis (N = 30 individuals) and a cohort of resilient agers carrying a SERPINE1 (PAI-1) mutation (N = 27 individuals). PPA signatures distinguished SERPINE1 mutation carriers from affected individuals and provided sufficient resolution to discriminate among cirrhosis disease stages. In summary, we present PPA 526 and PPA 1514, the first scalable plasma proteoform panels capable of tracking hundreds to thousands of targets in a few minutes per sample.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsMass SpectrometryBlood ProteinsProteomeHumansLiver CirrhosisPlasminogen Activator Inhibitor 1

Stichwörter der Autor:innen

Acetonitrile PrecipitationCharge DetectionDirect Mass TechnologyI2MSMass SpectrometryPlasmaProteoformsTop-Down Proteomics

Substanzen

Blood ProteinsProteomePlasminogen Activator Inhibitor 1

Autor:innen und Institutionen

  • Proteomics Center of Excellence, Northwestern University, Evanston, Illinois60208, United States.
  • Department of Chemistry, Northwestern University, Evanston, Illinois60208, United States.
  • Chemistry of Life Processes Institute, Evanston, Illinois60208, United States.
  • Department of Molecular Biosciences, Northwestern University, Evanston, Illinois60208, United States.
  • Division of Gastroenterology & Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois60611, United States.
  • Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York10029, United States.

ORCID-Profile: Indira Pla, Vincent White, Troy D Fisher, Michael A R Hollas, Eleonora Forte, John T Wilkins, Neil L Kelleher

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Sanchez, A., Pla, I., Peterson, K. N., White, V., Fisher, T. D., Hollas, M. A. R., Su, T., Le, N. H. V., Harrington, C. R., Cravedi, P., Assis, D. N., Barrios, P., Banea, T. E., Ladner, D. P., Forte, E., Lucky, M., Wilkins, J. T., Vaughan, D. E., Caldwell, M. A., …, & Kelleher, N. L. (2026). Targeted Analysis of >1500 Plasma Proteoforms via Individual Ion Mass Spectrometry. Journal of Proteome Research, 25(11), 5985-6002. https://doi.org/10.1021/acs.jproteome.6c00449

Vancouver

Sanchez A, Pla I, Peterson KN, White V, Fisher TD, Hollas MAR, et al. Targeted Analysis of >1500 Plasma Proteoforms via Individual Ion Mass Spectrometry. Journal of Proteome Research. 2026;25(11):5985-6002. doi:10.1021/acs.jproteome.6c00449

BibTeX
@article{Sanchez2026,
  author = {Sanchez, Aniel and Pla, Indira and Peterson, Katrina N and White, Vincent and Fisher, Troy D and Hollas, Michael A R and Su, Taojunfeng and Le, Nhat Hoang Van and Harrington, Claire R and Cravedi, Paolo and Assis, David N and Barrios, Paola and Banea, Therese Elaine and Ladner, Daniela P and Forte, Eleonora and Lucky, Matthew and Wilkins, John T and Vaughan, Douglas E and Caldwell, Michael A and McGee, John P and Kelleher, Neil L},
  title = {Targeted Analysis of >1500 Plasma Proteoforms via Individual Ion Mass Spectrometry},
  journal = {Journal of Proteome Research},
  year = {2026},
  volume = {25},
  number = {11},
  pages = {5985--6002},
  doi = {10.1021/acs.jproteome.6c00449}
}
Kostenlos starten →